Caused by heart and/or blood-vascular system disorders, cardiovascular (CDV) diseases kill almost 17 million people annually. The cardiovascular market can be divided the following key segments: cardiac surgery, cardiac rhythm management (abbreviated as CRM) and interventional cardiology. There is a wide range of products on offer in the market: defibrillators, introducers, catheters, pacemakers, among others.
The growth of the cardiovascular market is driven by the aging population, rising incidence of chronic CDV, innovations and technology advancements in the cardiovascular industry and constantly improving treatment capabilities. The USA is the largest cardiovascular market, with AstraZeneca , Merck & Co. , Bristol-Myers Squibb (BMS), Novartis , Sanofi-Aventis and Pfizerbeing amid the most prominent market participants.
Comprehensive assessment of the cardiovascular market at various geographical scales and over different time spans is provided in the research reports found under this catalogue. Data demand and supply trends, research and development activities, and leading market players are at hand in the reports. Moreover, future prospects for the market are disclosed in the research reports.
Publications found:
122
Sort by:
Global Cardiovascular Partnering 2014-2021: Deal trends, players and financials
US$ 3,495.00
... heart failure, Coronary artery disease, Ductus arteriosus, Fatigue, Hypercholesterolemia, Hypertension, Intermittent claudication, Ischemic heart disease, Limb ischemia, Marfan's Syndrome, Myocardial Infarction, Oedema (excess fluid), Palpitations, Peripheral arterial disease, Thrombus (blood clot), Valvular ...
April 2021
550 pages
Congenital Heart Disease Global Clinical Trials Review, H1, 2020
US$ 2,500.00
... coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
May 2020
287 pages
Chronic Stable Angina Global Clinical Trials Review, H1, 2019
US$ 2,500.00
... of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports ...
April 2019
153 pages
Global Cardiology Surgery, Devices and Drugs Industry Market Research 2019
US$ 2,600.00
... overall research conclusions are offered. Key players in global Cardiology Surgery, Devices and Drugs market include: Pfizer Sanofi AstraZeneca Novartis ... What are the Cardiology Surgery, Devices and Drugs market opportunities and threats faced by the vendors in the global Cardiology Surgery, Devices and Drugs ...
February 2019
150 pages
Global Cardiomyopathy Industry Market Research 2019
US$ 2,600.00
... of the Cardiomyopathy market? 9. What are the Cardiomyopathy market challenges to market growth? 10. What are the Cardiomyopathy market opportunities and threats faced by the vendors in the global Cardiomyopathy market? Objective of Studies ...
February 2019
149 pages
Prosthetic Heart Valves: Market Research Report
US$ 5,600.00
... report analyzes the worldwide markets for Prosthetic Heart Valves in US$ by the following Segments: Tissue Heart Valves, Transcatheter Heart Valves, and Mechanical Heart Valves. The report provides separate ... are provided for the period 2015 through 2024. Market data and analytics are derived from primary and ...
January 2019
164 pages
Regurgitation Global Clinical Trials Review, H1, 2018
US$ 2,500.00
... clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company ...
June 2018
57 pages
Reperfusion Injury Global Clinical Trials Review, H1, 2018
US$ 2,500.00
... to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status ...
June 2018
115 pages
France Cardiac Rhythm Management Procedures Outlook to 2025
US$ 2,995.00
... based models to estimate and forecast the procedure volumes. The objective is to ... numbers. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes. SCOPE France Cardiac Rhythm Management (CRM) Procedures volumes by segments - Cardiac ...
June 2018
26 pages
France Cardiac Assist Procedures Outlook to 2025
US$ 2,995.00
France Cardiac Assist Procedures Outlook to 2025 SUMMARY GlobalData’s new report, France Cardiac Assist Procedures Outlook to 2025, provides key procedures data on the France Cardiac Assist Procedures. The report provides procedure volumes within market segments - Total Artificial Heart (TAH ...
June 2018
16 pages
Global Cardiology Software Industry Market Research 2018
US$ 2,600.00
... of the Cardiology Software market? 9. What are the Cardiology Software market challenges to market growth? 10. What are the Cardiology Software market opportunities and threats faced by the vendors in the global Cardiology Software market? Objective of Studies ...
May 2018
160 pages
